Clinical Trial Update: UW Withdraw From Tobacco Study [Phase 2]

View source ↗

Summary

The University of Wisconsin, Madison withdrew from a Phase 2 tobacco dependence trial; the study is listed as completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Dependence

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Tobacco Dependence | Phase 2 | Status: COMPLETED | Results posted: 2023-12-01